Learning Objectives

After completion of this module, you should be able to:

•    Assess your compliance with evidence-based measures for the management of patients with asthma and the patient outcomes achieved from your care
•    Select and implement appropriate interventions to improve compliance with the measures
•    Compare and contrast practice before and after the intervention(s) to identify possible improvements in the management of patients with asthma and the patient outcomes achieved from your care
 

Faculty 

Module Authors:
•    Giselle Mosnaim, MD MS FAAAAI – Activity Chair
North Shore University Health System, Evanston IL
•    Stuart L. Abramson, MD PhD FAAAAI
Shannon Medical Center, San Angelo TX
•    Caroline C. Horner, MD FAAAAI
Washington University, St. Louis MO
•    John Oppenheimer, MD FAAAAI
Pulmonary and Allergy Associates, Denville NJ
•    Matthew A. Rank, MD FAAAAI
Mayo Clinic and Foundation, Scottsdale AZ
•    Kristin C. Sokol, MD
Beth Israel Deaconess Medical Center, Brookline MA
•    Susan L. Symington, PA
Northwest Asthma and Allergy Center, Seattle WA

Content Reviewers:
•    Thomas B. Casale, MD FAAAAI
University of South Florida, Tampa FL
•    Michael Schatz, MD MS FAAAAI
Kaiser Permanente, San Diego, CA

CME/MOC Committee Reviewers:
•    Anne M. Ditto, MD FAAAAI
Northwestern University, Chicago IL
•    Benjamin Prince, MD
Nationwide Children’s Hospital, Columbus OH

AAAAI Staff:
•    Steven Folstein, MFA M.Ed.
Director of Education
•    Lauri Sweetman
Program Manager, Asthma-IQ

Faculty Disclosures

Authors and Reviewers disclosed the following relevant financial relationships:

Dr. Mosnaim: consultant for Teva, Novartis, and Boehringer-Ingleheim; advisory board member for GlaxoSmithKline
Dr. Horner: NIH/NHLBI AsthmaNet research grant
Dr. Casale: advisory board member for Sanofi-Aventis, Teva, Aviragen, Aimmune, Novartis, Genentech, Boerhinger-Ingelheim, and AstraZeneca; consultant for Circassia

All other authors, reviewers, and staff disclosed no relevant financial relationships.

CME Statement

Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this PI CME activity for a maximum of 20.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Allergy and Immunology MOC Statement
The American Board of Allergy and Immunology has approved this performance improvement module to meet the requirements for Part IV of their Maintenance of Certification (MOC) program.

American Board of Allergy and Immunology MOC Statement

The American Board of Allergy and Immunology has approved this performance improvement module to meet the requirements for Part IV of their Maintenance of Certification (MOC) program.

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

Release and Renewal Dates

Original release date: November 1, 2017. Reviewed by Matthew Rank, MD FAAAAI on May 26, 2019. Valid for credit through October 31, 2020.